Skip Navigation

Phase I/Ib Study of AKT Inhibitor Ipatasertib with Chemoradiation for Locally Advanced Head and Neck Cancer

Brief Summary

Type:
Head and Neck Cancers

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT05172245

Study #:
STUDY00149540

Start Date:
Mar 09, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05172245

View Complete Trial Details & Eligibility at ClinicalTrials.gov